1. The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer
   Lakshmipathi Vadlakonda et al, 2020, Journal of Diabetes & Metabolic Disorders CrossRef
2. Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy
   Le Zhang et al, 2022, Frontiers in Pharmacology CrossRef
3. Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide
   Gabriele Maurer et al, 2019, International Journal of Molecular Sciences CrossRef
4. Structure, regulation, and biological functions of TIGAR and its role in diseases
   Jie Tang et al, 2021, Acta Pharmacologica Sinica CrossRef
5. KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non‐small cell lung cancer
   Xue Zhou et al, 2022, Investigational New Drugs CrossRef
6. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function
   N.V. Rajeshkumar et al, 2015, Cancer Research CrossRef
7. Cardioprotective effect of miRNA-22 on hypoxia/reoxygenation induced cardiomyocyte injury in neonatal rats
   Jian Yang et al, 2016, Gene CrossRef
8. Functions of SAGA in development and disease
   Li Wang et al, 2014, Epigenomics CrossRef
9. C5a promotes the proliferation of human nasopharyngeal carcinoma cells through PCAF-mediated STAT3 acetylation
   KEMIN CAI et al, 2014, Oncology Reports CrossRef
10. The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30II and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphoma
    Tetiana Hutchison et al, 2018, Virology CrossRef
11. Nanoparticle delivery of si-Notch1 modulates metabolic reprogramming to affect 5-FU resistance and cell pyroptosis in colorectal cancer
    Dan-dan Li et al, 2024, Cancer Nanotechnology CrossRef
12. Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia
    Malak Yahia Qattan et al, 2017, PLOS ONE CrossRef
13. Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers
    Weifen Zhang et al, 2018, Frontiers in Oncology CrossRef
14. Expression alterations define unique molecular characteristics of spinal ependymomas
    Anbarasu Lourdusamy et al, 2015, Oncotarget CrossRef
15. The E3 ubiquitin ligase TRIM31 is involved in cerebral ischemic injury by promoting degradation of TIGAR
    Shenglan Zeng et al, 2021, Redox Biology CrossRef
16. The diverse role of TIGAR in cellular homeostasis and cancer
    Ji Geng et al, 2018, Free Radical Research CrossRef
17. A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy
    Mohammad Ghanbari et al, 2019, Current Cancer Therapy Reviews CrossRef
18. Molecular cloning and modeling of the Tp53-induced glycolysis and apoptotic regulator (TIGAR) from the Pacific white shrimp Litopenaeus vannamei and its expression in response to hypoxia
    Laura Camacho-Jiménez et al, 2019, Fish & Shellfish Immunology CrossRef
19. Regulation of p53 stability as a therapeutic strategy for cancer
    Zhifei Xu et al, 2021, Biochemical Pharmacology CrossRef
20. Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells
    Travis Leung et al, 2013, Breast Cancer Research CrossRef
21. Fructose 2,6-Bisphosphate in Cancer Cell Metabolism
    Ramon Bartrons et al, 2018, Frontiers in Oncology CrossRef
22. Notch1/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer
    Mian Xie et al, 2021, Cell Death & Disease CrossRef